ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 490

$772K Total Retail Price of All Prescriptions

Rank: 7 out of 490

579 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 579 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 11,962 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 524 406 1 1
OMEPRAZOLE 512 457 2 3
METOPROLOL TARTRATE 443 428 3 6
LEVOTHYROXINE SODIUM 442 376 4 4
LISINOPRIL 422 332 5 2
FUROSEMIDE 421 361 6 8
PRAVASTATIN SODIUM 407 351 7 14
METFORMIN HCL 399 328 8 7
AMLODIPINE BESYLATE 349 338 9 5
METOPROLOL SUCCINATE 327 281 10 13
LOSARTAN POTASSIUM 261 214 11 27
WARFARIN SODIUM 252 198 12 17
HYDROCODONE-ACETAMINOPHEN 249 185 S3 13 9
GABAPENTIN 243 212 14 12
HYDROCHLOROTHIAZIDE 229 191 15 10
ATENOLOL 205 155 16 15
CRESTOR 176 163 17 23
ALENDRONATE SODIUM 169 159 18 40
ISOSORBIDE MONONITRATE ER 162 148 19 37
ZETIA 151 127 20 59
SERTRALINE HCL 145 105 21 21
PANTOPRAZOLE SODIUM 143 116 22 26
JANTOVEN 133 133 23 148
LANTUS SOLOSTAR 127 111 24 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 112 24 36
ALLOPURINOL 125 106 26 54
TAMSULOSIN HCL 114 102 27 34
DIOVAN 111 110 28 43
FLUOXETINE HCL 110 109 29 52
CITALOPRAM HBR 106 88 30 18
CLOPIDOGREL 106 104 30 19
JANUVIA 96 95 32 53
PREDNISONE 96 89 32 31
DIGOXIN 93 77 34 56
LORAZEPAM 93 78 34 207
ATORVASTATIN CALCIUM 92 83 36 11
TRAMADOL HCL-ACETAMINOPHEN 91 89 37 208
LOSARTAN-HYDROCHLOROTHIAZIDE 89 68 38 103
POTASSIUM CHLORIDE 88 86 39 28
SPIRIVA 86 71 40 25
ADVAIR DISKUS 86 83 40 30
SINGULAIR 86 72 40 91
FLUTICASONE PROPIONATE 85 76 43 49
DONEPEZIL HCL 84 84 44 66
LOVASTATIN 84 84 44 45
LANTUS 81 63 46 55
MONTELUKAST SODIUM 80 64 47 138
GLYBURIDE 78 56 R 48 68
GLYBURIDE MICRONIZED 77 57 R 49 180
CLONIDINE HCL 77 71 49 131
PLAVIX 75 75 51 41
KLOR-CON M20 74 28 52 90
TRICOR 74 40 52 94
FAMOTIDINE 69 67 54 126
ZOLPIDEM TARTRATE 66 66 55 29
AZITHROMYCIN 65 55 56 38
PROAIR HFA 61 52 57 61
NAMENDA 57 57 58 80
CARVEDILOL 57 56 58 22
GLIMEPIRIDE 55 42 60 42
GEMFIBROZIL 55 38 60 120
PEN NEEDLE 55 49 60 64
LOVAZA 53 39 63 171
AMITRIPTYLINE HCL 52 50 R 64 76
VYTORIN 51 49 65 263
CHOLESTYRAMINE LIGHT 51 40 10 65 263
KLOR-CON 10 51 47 65 263
RAMIPRIL 50 50 68 123
NEXIUM 50 49 68 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.